Article metrics

PDF
Extended report
A phase III, multicentre, randomised, double-blind, active-controlled, parallel-group trial comparing safety and efficacy of HD203, with innovator etanercept, in combination with methotrexate, in patients with rheumatoid arthritis: the HERA study

Statistics from Altmetric.com

Online download statistics by month:

Online download statistics by month: February 2016 to June 2019

AbstractFullPdf
Feb 20165343590
Mar 201642298104
Apr 20161613430
May 2016912721
Jun 20161352824
Jul 2016802916
Aug 20161452528
Sep 2016881518
Oct 20161132310
Nov 2016832819
Dec 2016146936155
Jan 20179882290
Feb 20172583730
Mar 20171724851
Apr 20171602812
May 2017924225
Jun 20171313126
Jul 20172302920
Aug 20171832617
Sep 20171522120
Oct 20171371611
Nov 20171722623
Dec 2017140119
Jan 20182042723
Feb 2018158199
Mar 20181631710
Apr 2018176227
May 2018210156
Jun 20181971712
Jul 2018156157
Aug 201818484
Sep 20181812012
Oct 20181222211
Nov 201811741
Dec 201811695
Jan 201912775
Feb 2019103147
Mar 201910161
Apr 201988108
May 20199497
Jun 20196988
Total8702964992